Search
for

    Sort by

    Research 781–810 of 1000+

    1. Low-dose oral minoxidil for androgenetic alopecia is not associated with blood pressure changes in patients also taking other antihypertensive medications: A multi-center cohort study using TriNetX Journal of the American Academy of Dermatology · 2025
    2. Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review Journal of Clinical Medicine · 2025
    3. ASSESSING THE EFFECTIVENESS AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN ANDROGENETIC ALOPECIA: A 24-WEEK CLINICAL STUDY International Journal of Scientific Research · 2025
    4. Efficacy of Oral Supplementation with Serenoa Repens, Pumpkin Seed Extract and Cysteine Combined with Topical Minoxidil 5% Vs Topical Minoxidil 5% Alone in Androgenic Alopecia A Randomised Assessor-Blinded 6-Month, Superiority Trial Clinical & Experimental Dermatology and Therapies · 2025
    5. Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial Archives of Dermatological Research · 2025
    6. Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss. Journal of the American Academy of Dermatology · 2025
    7. TRICHOGRAM OBSERVATION OF ORAL IVERMECTIN THERAPY IN SCABIOSIS AND OTITIS EXTERNA IN DOMESTIC CATS Buletin Veteriner Udayana · 2025
    8. Treatment of Androgenetic Alopecia with Low Dose Oral Minoxidil Monotherapy Compared to Combination Therapy with Dutasteride or Finasteride Journal of the American Academy of Dermatology · 2025
    9. Low-dose oral minoxidil for androgenetic alopecia is not associated with significant changes in alcohol consumption: a retrospective study of 21,971 patients Skin Appendage Disorders · 2025
    10. Low‐dose oral minoxidil in alopecia: evaluating blood pressure changes in patients with abnormal blood pressure—a retrospective study International Journal of Dermatology · 2025
    11. Efficacy of oral spironolactone in the treatment of androgenetic alopecia in female patients: A case series of 11 patients 2025
    12. Expert Consensus Offers Guidance for Treating Hair Loss With Low-Dose Oral Minoxidil JAMA · 2024
    13. Gender differences in adverse effects and dosing practices of low-dose oral minoxidil for androgenetic alopecia: a retrospective analysis of 310 patients Skin Appendage Disorders · 2024
    14. Phototoxic reaction to oral terbinafine due to Tinea capitis in a child. PubMed · 2024
    15. Therapeutic potential of oral tofacitinib in alopecia areata: a retrospective study International Journal of Research in Dermatology · 2024
    16. Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions Journal of Cosmetic Dermatology · 2024
    17. Test With Oral Administration of Clomiphene May Add to Differential Diagnosis of Severe Hyperandrogenism in Postmenopausal Women - A Case Report Brazilian Journal of Case Reports · 2024
    18. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management Archives of Dermatological Research · 2024
    19. 51297 Low dose oral minoxidil in COVID-19-associated telogen effluvium. A retrospective analysis of 69 patients. Journal of the American Academy of Dermatology · 2024
    20. Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium Archives of Dermatological Research · 2024
    21. Side Effects’ Frequency Assessment of Low Dose Oral Minoxidil in Male Androgenetic Alopecia Patients Skin Appendage Disorders · 2024
    22. Scientific Abstracts: 16th Asian Congress of Oral and Maxillofacial Surgery 2024, Chennai Journal of Maxillofacial and Oral Surgery · 2024
    23. Amino Acids Oral Treatment for the Amelioration of Skin, Hair, and Nails Conditions: An Open-Label Study Current research in nutrition and food science · 2024
    24. Low-dose oral minoxidil improves hair length and global hair density in short anagen syndrome Journal of the American Academy of Dermatology · 2024
    25. Thoughts on “Dermatologists’ Knowledge, Attitude, and Practice Pattern Toward Low-Dose Oral Minoxidil in Hair Loss in Saudi Arabia” [Letter] Clinical, cosmetic and investigational dermatology · 2024
    26. Low-dose oral minoxidil for treatment of androgenetic alopecia: gender differences in blood pressure and hypotension-related adverse effects Journal of the American Academy of Dermatology · 2024
    27. Response to “Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study” Journal of the American Academy of Dermatology · 2024
    28. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia Expert Opinion on Pharmacotherapy · 2024
    29. COMPARING THE EFFECTIVENESS OF ORAL ISOTRETINOIN AND CYPROTERONE COMPOUND IN ACNE TREATMENT AMONG ADULT FEMALES WITH CUTANEOUS HYPERANDROGENISM: A PROSPECTIVE STUDY. 2024
    30. Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran Journal of Cosmetic Dermatology · 2023